Drugs

FDA Webinar - FDA’s Overview of the Regulatory Guidance for the Development and Approval of Biosimilar Products in the US

The FDA recorded a webinar titled, FDA’s Overview of the Regulatory Guidance for the Development and Approval of Biosimilar Products in the US. Dr. Leah Christl, Ph.D, Associate Director for Therapeutic Biologics, presented information on the regulation of biosimilar products. This presentation was recorded to help FDA Advisory Committee members and the public gain useful insight into the unique regulatory features that are ascribed to biosimilar products.

 


If you have never attended an Adobe Connect meeting before:

 
 
 
 
 
Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.

Page Last Updated: 01/02/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English